Skip to main content
  • En
  • Français

Top Navigation

  • Newsroom
  • Contact Us

Main navigation

  • About Us
  • Products
  • Clinical Studies
  • Investors
  • News
  • En
  • Français

Bone Therapeutics receives clearance for ALLOB® phase II trial in spine fusion

Date
Mon, 09/01/2014 - 12:00
Year
2014
Filter Criteria
Press Releases
Document Upload
20140912_BoneTherapeutics_ALLOBIF_Final.pdf88.75 KB
Wallonie Eu Flag

BioSenic SA
Avenue Léon champagne, 3
1480 Saintes – Belgium
info@biosenic.com
 

Sign upfor our press releases

Receive information about BioSenic

Sign Up

Footer menu

  • Privacy Policy
  • Trademarks Copyrights
  • Users conditions